Fujita Health University Reports Findings in Gastric Cancer (Safe implementation of robotic gastrectomy for gastric cancer under the requirements for universal health insurance coverage: a retrospective cohort study using a nationwide registry …): Oncology – Gastric Cancer

2021 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Oncology - Gastric Cancer is the subject of a report. According to news reporting out of Aichi, Japan, by NewsRx editors, research stated, “Robotic gastrectomy (RG) has increased since being covered by universal health insurance in 2018. However, to ensure patient safety the operating surgeon and facility must meet specific requirements.”

Our news journalists obtained a quote from the research from Fujita Health University, “We aimed to determine whether RG has been safely implemented under the requirements for universal health insurance in Japan. Data of consecutive patients with primary gastric cancer who underwent minimally invasive total or distal gastrectomy-performed by a surgeon certified by the Japan Society for Endoscopic Surgery (JSES) endoscopic surgical skill qualification system (ESSQS) between October 2018 and December 2019-were extracted from the gastrointestinal surgery section of the National Clinical Database (NCD). The primary outcome was morbidity over Clavien-Dindo classification grade IIIa. Patient demographics and hospital volume were matched between RG and laparoscopic gastrectomy (LG) using propensity score-matched analysis (PSM), and the short-term outcomes of RG and LG were compared. After PSM, 2671 patients who underwent RG and 2671 who underwent LG were retrieved (from a total of 9881), and the standardized difference of all the confounding factors reduced to 0.07 or less. Morbidity rates did not differ between the RG and LG patients (RG, 4.9% vs. LG, 3.9%; p = 0.084). No difference was observed in 30-day mortality (RG, 0.2% vs. LG, 0.1%; p = 0.754). The reoperation rate was greater following RG (RG, 2.2% vs. LG, 1.2%; p = 0.004); however, the duration of postoperative hospitalization was shorter (RG, 10 [8-13] days vs. LG, 11 [9-14] days; p< 0.001).”

According to the news editors, the research concluded: “Insurance-covered RG has been safely implemented nationwide.”

This research has been peer-reviewed.

For more information on this research see: Safe implementation of robotic gastrectomy for gastric cancer under the requirements for universal health insurance coverage: a retrospective cohort study using a nationwide registry database in Japan. Gastric Cancer, 2021. Gastric Cancer can be contacted at: Springer, One New York Plaza, Suite 4600, New York, Ny, United States. (Springer - www.springer.com; Gastric Cancer - http://www.springerlink.com/content/1436-3291/)

Our news journalists report that additional information may be obtained by contacting Koichi Suda, Dept. of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan. Additional authors for this research include Hiroyuki Yamamoto, Tatsuto Nishigori, Kazutaka Obama, Yukie Yoda, Makoto Hikage, Susumu Shibasaki, Tsuyoshi Tanaka, Yoshihiro Kakeji, Masafumi Inomata, Yuko Kitagawa, Hiroaki Miyata, Masanori Terashima, Hirokazu Noshiro and Ichiro Uyama.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10120-021-01257-7. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the journal Gastric Cancer is: Springer, One New York Plaza, Suite 4600, New York, Ny, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)